News

Royal Philips, a global leader in health technology, and The Spectranetics Corporation, a U.S.-based global leader in vascular intervention and lead management solutions, announced that they have entered into a definitive merger agreement....

CardioFocus, Inc., a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF), announced that its HeartLight Endoscopic Ablation System is being featured in...

Boehringer Ingelheim announced findings from GLORIA™-AF which show that people with non-valvular atrial fibrillation (AF) with few or no symptoms are more likely to have had a stroke prior to AF diagnosis than symptomatic AF patients.1 This...

Medtronic plc announced new data showing that use of its cardiac resynchronization therapy (CRT) devices - with its proprietary AdaptivCRT(TM) and EffectiveCRT(TM) algorithms - results in lower healthcare system costs, and improves therapy...

International, All-Woman Faculty Deliberates Clinical Workflow at Scientific Symposium VIENNA, Austria and BERLIN, Germany, June 20, 2017 – Physicians exchanged ideas on MR conditional devices in the scientific symposium “Clinical Decision...

Continuing its leadership in the detection, reduction, and treatment of atrial fibrillation (AF), Medtronic plc announced that its Reactive ATP(TM) therapy slows the progression of AF in patients with implanted cardiac devices. A robust,...

CardioFocus, Inc. announced the electrophysiology team at Na Homolce Hospital in Prague, Czech Republic is the first to successfully treat 500 patients using the HeartLight® Endoscopic Ablation System. The HeartLight System is a visually...

Aegis Medical Innovations Inc. (Aegis) announced that it has received Investigational Testing Authorization (ITA) approval from Health Canada to initiate a clinical trial called LASSO-AF in Canada for its medical device the Sierra Ligation...

SentreHEART, Inc., the manufacturer of the LARIAT® Suture Delivery Device (LARIAT) for percutaneous left atrial appendage (LAA) closure announces FDA approval to expand to Stage II of the aMAZE Trial. The approval comes as a result of...

The American Academy of Family Physicians issued a Clinical Practice Guideline that will help guide clinicians in the pharmacologic management of atrial fibrillation.  Atrial fibrillation is one of the most common types of arrhythmia in...